InvestorsHub Logo
Followers 8
Posts 147
Boards Moderated 0
Alias Born 10/18/2023

Re: kund post# 443843

Saturday, 12/23/2023 2:35:02 PM

Saturday, December 23, 2023 2:35:02 PM

Post# of 462446
These videos were produced in cooperation with the Australian Rett Association. This organization wouldn't be promoting a drug that it didn't believe provides therapeutic benefit, especially when Daybue is already available (despite its terrible symptoms). And there are more stories like this that remain unknown to the rest of the world, for now.

Blarcamesine isn't a miracle drug but it does provide benefit and should be approved. If and when it is, there will be demand. And who knows, maybe if taken early enough it will allow for normal speech development. If not, it's still better than taking nothing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News